Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology
Neutropenia Clinical Trials
A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 Last
Arizona
Arizona Center for Cancer Care
Glendale Arizona 85306
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Desert Springs Cancer Care
Scottsdale Arizona 85255
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
California
California Cancer Associates for Research and Excellence
Fresno California 93720
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Beaver Medical Group
Highland California 92346
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
California Cancer Associates for Research and Excellence
Los Angeles California 92025
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
North County Oncology
Oceanside California 92056
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Hematology Oncology Medical Group
Orange California 92868
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
View More »
Sarcoma Oncology
Santa Monica California 90403
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Florida
University Cancer Institute
Boynton Beach Florida 33426
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Research- Hen/Onc Associates of the Treasure Coast
Port St. Lucie Florida 34952
Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer
Georgia
Northeast Georgia Cancer Care, LLC
Athens Georgia 30607
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Kentucky
Kentucky Cancer Clinic
Hazard Kentucky 41701
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda Maryland 20892
Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide
New York
Memorial Sloan-Kettering Cancer Center
New York New York 10065
A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome
University of Rochester Medical Center
Rochester New York 14642
A Phase 3 clinical study for patients with Febrile Neutropenia
Oregon
Good Samaritan Hospital, Corvallis
Corvallis Oregon 97330
Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia
Tennessee
Associates in Oncology & Hematology
Chattanooga Tennessee 37421
Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer
Texas
The University of Texas, Health Science Center at San Antonio
San Antonio Texas 78229
Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer
Australia
Research Site
Bendigo Victoria 3550
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Shepparton Victoria 3630
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Tweed Heads New South Wales 2485
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Wodonga Victoria 3690
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Austria
Research Site
Eggenburg 3730
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Graz 8036
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Vöcklabruck 4840
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Wien 1030
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Wien 1090
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Brazil
Investigational Site Number 004
Curitiba 81520-060Updated
A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer
Investigational Site Number 006
Lajeado 95900-000Updated
A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer
Investigational Site Number 005
Porto Alegre 90035-903Updated
A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer
Investigational Site Number 001
Santo Andre 09050-360Updated
A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer
Investigational Site Number 002
São Paulo 01321-001Updated
A clinical research study of CABAZITAXEL (XRP6258), Prednisone, Ciprofloxacin and G-CSF (Granulocyte colony-stimulating factor) for the treatment of Prostate Cancer
Canada
Research Site
Moncton New Brunswick E1C 6Z8
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Montreal Quebec H2W 1T8
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Sault Ste. Marie Ontario P6B 0A8
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
China
Cancer Institute and Hospital, CAMS
Beijing
A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Beijing 100021
Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia
Beijing Cancer Hospital
Beijing 100142
Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor
Shanghai Pulmonary Hospital
Shanghai Shanghai 200433
A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia
Czech Republic
Nemocnice Znojmo
Znojmo 66902
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
France
Research Site
Alès Cédex 30103
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Arras 62000
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Besançon Cedex 25030
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Brest Cedex 2 29609
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Créteil 94010
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
View More »
Research Site
Grenoble Cedex 9 38043
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Marseille 13009
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Montluçon 03100
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Neuilly sur Seine 92202
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
Research Site
Nimes Cedex 2 30900
A clinical trial seeking patients for a research study for the treatment of Chemotherapy-induced Febrile Neutropenia
First 1 2 3 Last